422 results on '"Chambers, Daniel C."'
Search Results
2. Erratic tacrolimus levels at 6 to 12 months post-lung transplant predicts poor outcomes
3. Sex- and Race-Based Differences in the Treatment of Interstitial Lung Diseases in North America and Australasia
4. Contribution of skin cancer to overall healthcare costs of lung transplantation in Queensland, Australia
5. Safety, tolerability, and efficacy of pirfenidone in patients with rheumatoid arthritis-associated interstitial lung disease: a randomised, double-blind, placebo-controlled, phase 2 study
6. Multimodal Transplant-clinic–based Skin Cancer Prevention Education for Organ Transplant Recipients: Feasibility Study
7. Destructive and topical treatments of skin lesions in organ transplant recipients and relation to skin cancer
8. Cloaking antibodies are prevalent in Burkholderia cepacia complex infection and their removal restores serum killing.
9. Exertional Desaturation During the 6-Minute Walk Test vs Daily Life in People With Fibrotic Interstitial Lung Disease
10. Management of infectious disease syndromes in thoracic organ transplants and mechanical circulatory device recipients: a Delphi panel
11. Chronic Lung Allograft Dysfunction: Phenotypes and the Future
12. Incidence and outcome of post-transplant lymphoproliferative disorders in lung transplant patients: Analysis of ISHLT Registry
13. The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: 23rd pediatric heart transplantation report—2020; focus on deceased donor characteristics
14. The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: 37th adult lung transplantation report — 2020; focus on deceased donor characteristics
15. The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: 37th adult heart transplantation report—2020; focus on deceased donor characteristics
16. The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Twenty-third pediatric lung transplantation report — 2020; focus on deceased donor characteristics
17. Telomere length and immunosuppression in non-idiopathic pulmonary fibrosis interstitial lung disease
18. Genomic analyses of Burkholderia respiratory isolates indicates two evolutionarily distinct B. anthina clades
19. High intensity interval training versus moderate intensity continuous training for people with interstitial lung disease: protocol for a randomised controlled trial
20. The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Twenty-second pediatric lung and heart-lung transplantation report—2019; Focus theme: Donor and recipient size match
21. The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-sixth adult heart transplantation report — 2019; focus theme: Donor and recipient size match
22. The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Twenty-second pediatric heart transplantation report – 2019; Focus theme: Donor and recipient size match
23. The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-sixth adult lung and heart–lung transplantation Report—2019; Focus theme: Donor and recipient size match
24. Risk of anastomotic dehiscence in patients with pulmonary fibrosis transplanted while receiving anti-fibrotics: Experience of the Australian Lung Transplant Collaborative
25. Bronchiolitis obliterans syndrome–free survival after lung transplantation: An International Society for Heart and Lung Transplantation Thoracic Transplant Registry analysis
26. Treatment of idiopathic pulmonary fibrosis and progressive pulmonary fibrosis: A position statement from the Thoracic Society of Australia and New Zealand 2023 revision.
27. A Methodological Approach to Identify Natural Compounds with Antifibrotic Activity and the Potential to Treat Pulmonary Fibrosis Using Single-Cell Sequencing and Primary Human Lung Macrophages
28. High-risk Prognostic Tumor Features of Squamous Cell Carcinomas in Organ Transplant Recipients Compared With the General Population
29. The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-fifth Adult Heart Transplantation Report—2018; Focus Theme: Multiorgan Transplantation
30. The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Twenty-first Pediatric Lung and Heart‒Lung Transplantation Report—2018; Focus Theme: Multiorgan Transplantation
31. The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-fifth adult lung and heart-lung transplant report—2018; Focus theme: Multiorgan Transplantation
32. The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Twenty-first pediatric heart transplantation report—2018; Focus theme: Multiorgan Transplantation
33. Azithromycin Partially Mitigates Dysregulated Repair of Lung Allograft Small Airway Epithelium
34. Endothelial Glycocalyx Shedding Predicts Donor Organ Acceptability and Is Associated With Primary Graft Dysfunction in Lung Transplant Recipients
35. Chronic Lung Allograft Dysfunction: Phenotypes and the Future
36. Safety, tolerability, and efficacy of pirfenidone in patients with rheumatoid arthritis-associated interstitial lung disease: a randomised, double-blind, placebo-controlled, phase 2 study
37. A Phase IIb Randomized Clinical Study of an Anti-αvβ6 Monoclonal Antibody in Idiopathic Pulmonary Fibrosis
38. Basal cell carcinomas in organ transplant recipients versus the general population: clinicopathologic study
39. Mycoplasma hominis and Ureaplasma urealyticum infections in the immediate post‐lung transplant period: A case series and literature review.
40. Understanding the pathogenesis of occupational coal and silica dust-associated lung disease
41. Towards truly ‘idiopathic’ pulmonary fibrosis
42. Phase 2B Study of Inhaled RVT-1601 for Chronic Cough in Idiopathic Pulmonary Fibrosis: A Multicenter, Randomized, Placebo-controlled Study (SCENIC Trial)
43. Artificial stone-associated silicosis in Queensland stonemasons: a retrospective cohort study of lung function over time
44. Phase 2B Study of Inhaled RVT-1601 for Chronic Cough in Idiopathic Pulmonary Fibrosis: A Multicenter, Randomized, Placebo-controlled Study (SCENIC Trial)
45. Treatment of idiopathic pulmonary fibrosis in Australia and New Zealand: A position statement from the Thoracic Society of Australia and New Zealand and the Lung Foundation Australia†
46. The interstitial lung disease multidisciplinary meeting: A position statement from the Thoracic Society of Australia and New Zealand and the Lung Foundation Australia†
47. The Emerging Importance of Skeletal Muscle Function in Assessing Candidates for Transplantation
48. Alveolar crystal burden in stone workers with artificial stone silicosis
49. Effect of 2D and 3D Culture Microenvironments on Mesenchymal Stem Cell-Derived Extracellular Vesicles Potencies
50. Genomic lung allograft surveillance—is it primer time?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.